LOW COST SCREENING TOOL FOR HOLLOW FIBER BIOREACTOR RAND

Information

  • Research Project
  • 2536524
  • ApplicationId
    2536524
  • Core Project Number
    R43CA076829
  • Full Project Number
    1R43CA076829-01
  • Serial Number
    76829
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/1/1998 - 26 years ago
  • Project End Date
    3/31/1999 - 25 years ago
  • Program Officer Name
    MOHLA, SURESH
  • Budget Start Date
    4/1/1998 - 26 years ago
  • Budget End Date
    3/31/1999 - 25 years ago
  • Fiscal Year
    1998
  • Support Year
    1
  • Suffix
  • Award Notice Date
    3/27/1998 - 26 years ago

LOW COST SCREENING TOOL FOR HOLLOW FIBER BIOREACTOR RAND

Hollow-fiber bioreactor technology is an economical alternative to traditional cell culture methods for the production of cells and cell- derived products, and is finding increased use for novel applications in the fields of tissue engineering, gene therapy, and pharmacology. Hollow-fiber bioreactors are also reducing the suffering of animals by serving as logical replacements for ascites production methods. However, a major drawback of hollow-fiber technology is an inherent lack of predictability; there is no efficient screening method to determine how well a new cell line will perform in a hollow-fiber system, or how well an established cell line will perform under new conditions. To address this problem, a small, inexpensive, and easy to use screening tool has been developed at CELLEX BIOSCIENCES. This tool incorporates the same fibers as in a production system, but requires no pumping for oxygenation or medium delivery so that dozens of conditions can be tested simultaneously in a single incubator. This research will be used to test the validity of this micro hollow-fiber screening tool as a predictor of cell line performance in large scale hollow fiber systems. This tool has the potential of substantially increasing the efficiency and reliability of hollow-fiber systems, much as screening tools such as 96-well plates have done for stirred tank systems. PROPOSED COMMERCIAL APPLICATION Most importantly, a low cost screening tool will be developed and validated to fill a current market need. CELLEX could also use this tool along with other information learned in this research to provide a battery of screening tests as an optimization service. In addition, a new medium formulation specifically optimized for hollow-fiber bioreactors could be developed in this research.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    396
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG2
  • Study Section Name
  • Organization Name
    BIOVEST INTERNATIONAL, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    Minneapolis
  • Organization State
    MN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    55433
  • Organization District
    UNITED STATES